DRGEM CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,670 KRW | -0.31% |
|
-1.53% | -7.11% |
| 2023 | DRGEM Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2022 | DRGEM Corporation's Equity Buyback announced on November 2, 2021, has expired. | CI |
| Sales 2022 | 110B 80.2M | Sales 2023 | 113B 82.2M | Capitalization | 115B 83.49M |
|---|---|---|---|---|---|
| Net income 2022 | 14.39B 10.48M | Net income 2023 | 9.19B 6.69M | EV / Sales 2022 | 1.03 x |
| Net cash position 2022 | 3.16B 2.3M | Net cash position 2023 | 2.96B 2.15M | EV / Sales 2023 | 0.99 x |
| P/E ratio 2022 |
8.12
x | P/E ratio 2023 |
12.5
x | Employees | 235 |
| Yield 2022 |
2.99% | Yield 2023 |
-
| Free-Float | 42.22% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.31% | ||
| 1 week | -1.53% | ||
| Current month | -4.82% | ||
| 1 month | -3.69% | ||
| 3 months | -10.46% | ||
| 6 months | -6.48% | ||
| Current year | -7.11% |
1 week
9 600.00
9 870.00
1 month
9 600.0010 300.00
Current year
9 600.0011 310.00
1 year
9 600.0012 600.00
3 years
7 710.0018 500.00
5 years
4 600.0025 850.00
10 years
4 600.0025 850.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jung-Byung Park
CEO | Chief Executive Officer | 61 | - |
Young-Min Seo
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Byung-Il Hwang
BRD | Director/Board Member | 58 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jung-Byung Park
CEO | Chief Executive Officer | 61 | - |
Min-Soo Byun
BRD | Director/Board Member | 51 | - |
Byung-Il Hwang
BRD | Director/Board Member | 58 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-22 | 9,670 | -0.31% | 27 908 |
| 24-04-22 | 9,700 | 0.00% | 14,054 |
| 24-04-19 | 9,700 | -1.22% | 3,197 |
| 24-04-18 | 9,820 | +0.61% | 6,671 |
| 24-04-17 | 9,760 | +1.14% | 5,416 |
End-of-day quote Korea S.E., April 22, 2024
More quotes
DRGEM CORPORATION is a Korea-based company mainly engaged in the manufacturing and distribution of diagnostic X-ray systems. The Company manufactures and sells diagnostic analog X-ray systems, diagnostic digital X-ray systems, diagnostic retrofit X-ray systems, as well as components of X-ray systems. The Companyâs main products include diagnostic x-ray systems, high voltage X-ray generators, digital upgrade systems, mobile x-ray systems, veterinary digital radiography systems, among others. The Company distributes its products within domestic and into overseas markets.
Calendar
2024-05-13
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -7.11% | 77.51M | |
| -7.72% | 13.99B | |
| -40.07% | 2.71B | |
| -16.70% | 2.21B | |
| -12.18% | 1.43B | |
| -.--% | 1.12B | |
| +48.67% | 521M | |
| +80.77% | 460M | |
| 0.00% | 210M | |
| +0.37% | 180M |
- Stock Market
- Equities
- A263690 Stock
